Nordea Investment Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-120,455
Closed -$481K 884
2025
Q4
$481K Sell
120,455
-15,294
-11% -$85K ﹤0.01% 856
2025
Q3
$1.17M Buy
135,749
+5,646
+4% +$54.8K ﹤0.01% 806
2025
Q2
$1.46M Buy
130,103
+4,101
+3% +$37.7K ﹤0.01% 773
2025
Q1
$1.21M Sell
126,002
-4,451
-3% -$45K ﹤0.01% 780
2024
Q4
$1.47M Buy
130,453
+8,552
+7% +$150K ﹤0.01% 737
2024
Q3
$3.52M Sell
121,901
-4,939
-4% -$127K ﹤0.01% 592
2024
Q2
$2.52M Buy
+126,840
New +$3.24M ﹤0.01% 658
2023
Q1
Sell
-23,490
Closed -$648K 961
2022
Q4
$648K Sell
23,490
-13,451
-36% -$386K ﹤0.01% 840
2022
Q3
$1.37M Sell
36,941
-29,113
-44% -$1.03M ﹤0.01% 738
2022
Q2
$2.01M Sell
66,054
-46,184
-41% -$1.35M ﹤0.01% 689
2022
Q1
$3.59M Sell
112,238
-22,792
-17% -$597K ﹤0.01% 635
2021
Q4
$3.75M Hold
135,030
﹤0.01% 630
2021
Q3
$3.98M Hold
135,030
0.01% 635
2021
Q2
$2.85M Buy
135,030
+22,959
+20% +$460K ﹤0.01% 658
2021
Q1
$2.31M Buy
+112,071
New +$2.13M ﹤0.01% 673

Other funds holding EVH

Nordea Investment Management's EVH Position: Q1 2026 in Review

Nordea Investment Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 120,455 shares — an estimated $481K sold.

Nordea Investment Management first reported a position in EVH in Q1 2021 and held it in 15 quarters. The position peaked at $3.98M in Q3 2021. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Nordea Investment Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Nordea Investment Management sold 120,455 Evolent Health shares in Q1 2026, an estimated $481K.
  • Nordea Investment Management first reported a position in Evolent Health in Q1 2021 and held it in 15 quarters.
  • Nordea Investment Management's Evolent Health position peaked at $3.98M in Q3 2021.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.